Compare Extra Space Storage, Inc. (EXR) vs Globus Medical Inc. Class A Common Stock (GMED) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Extra Space Storage, Inc. vs Globus Medical Inc. Class A Common Stock — how do they compare? Extra Space Storage, Inc. trades at $135.18 (market cap $28.26B), while Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B). The key difference: Extra Space Storage, Inc. is far larger — about 2.8× Globus Medical Inc. Class A Common Stock's market cap, and Extra Space Storage, Inc. pays a 4.85% dividend while Globus Medical Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Extra Space Storage, Inc. for 109 Days and Globus Medical Inc. Class A Common Stock for 0 Days on average.
| EXR | GMED | |
|---|---|---|
Market Cap | $28.26B | $10.25B |
Volume | 1,443,466 | 1,059,528 |
Sector | Real Estate | Health |
52-Week High | $152.85 | $96.82 |
52-Week Low | $126.67 | $58.33 |
Typical Hold Time | 109 Days | 0 Days |
Enterprise Value | $41.97B | $9.76B |
Dividend Yield | 4.85% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Extra Space Storage (EXR) trades at $133.74, down 0.23% today, with neutral technical signals and mixed analyst sentiment. The REIT shows strong fundamentals with consistent revenue growth from $3.3B (2024) to $3.4B (2025) and robust profitability (28.83% net margin). Recent quarters have seen earnings beats, with Q3 2026 results expected October 27, 2026. The company maintains solid operational performance with 94.2% same-store occupancy and recently announced leadership transition effective January 2027.
EXR presents a balanced risk-reward profile with 50% analyst buy ratings and $158.33 consensus price target (18% upside). Strengths include scale, diversified growth, and financial flexibility, while risks involve softer housing activity impact and elevated debt levels (46.63% debt-to-asset ratio). The stock offers income potential with $1.62 quarterly dividend, but investors should monitor interest rate sensitivity and competitive pressures in the self-storage sector.
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Extra Space Storage, Inc.
Extra Space Storage is a fully integrated real estate investment trust that owns, operates, and manages almost 2,100 self-storage properties in 41 states, with over 160 million net rentable square feet of storage space. Of these properties, approximately one half is wholly owned, while some facilities are owned through joint ventures and others are owned by third parties and managed by Extra Space Storage in exchange for a management fee.
Read more on EXR →About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →
